Why The Clorox Company (CLX) stock moved
The Clorox Company (CLX) shares rose 2.1% to $88.67 as of October 29, 2026, a modest gain from the prior close of $86.84. BestStocks flagged the session as a major change for CLX. Below, we break down what changed for CLX, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
CLX climbed 2.1% to $88.67
Clorox announced the appointment of Fabian Garcia, formerly of Unilever, as its new CEO, per a Wall Street Journal report and an SEC 8-K filing today. The stock rose 2.10% to $88.66 on above-average volume (1.66x expected), suggesting investor confidence in the leadership transition. Clorox's next earnings report (scheduled November 2, 2026; consensus EPS $1.07) will be the first under Garcia's leadership and a key test of how investors view the transition and dividend outlook.
What it means for The Clorox Company investors
For The Clorox Company investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 2.1% session move; The Clorox Company (CLX) moved +6.78% from $98.02 to $104.67 on 2026-08-04, reaching a new 30-day high on modestly elevated volume (1.8x the 5-day average). Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $90.43, implying +2.0% upside from $88.67. BestStocks rates the overall signal quality low (47/100). With earnings roughly 4 days out, the next report is the most likely near-term test of the move.
CLX price reaction
CLX last traded at $88.67, up $1.83 (+2.11%) from the previous close of $86.84. The session traded on 1.4× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $80.41 and $88.67, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on The Clorox Company (CLX)
The consensus analyst price target on The Clorox Company (CLX) is $90.43, 2.0% above the recent $88.67. Over the past 90 days analysts logged 0 upgrades, 13 maintains, and 0 downgrades. Here is how the bullish and bearish cases on CLX line up.
The bullish case
- Wall Street's consensus price target of $90.43 implies +2.0% upside from $88.67.
- The Street's most bullish target is $99.00 (+11.6%).
- Positive 2.1% session move.
- The Clorox Company (CLX) moved +6.78% from $98.02 to $104.67 on 2026-08-04, reaching a new 30-day high on modestly elevated volume (1.8x the 5-day average).
The bearish case
- The most bearish analyst target is $80.00 (-9.8%).
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 29, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CLX
Frequently asked questions about CLX
Why did The Clorox Company (CLX) stock move?
CLX rose 2.1% to $88.67. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did CLX stock rise?
CLX gained 2.11% ($1.83) versus the prior close of $86.84, last trading at $88.67 on 1.4× average volume.
When is The Clorox Company's next earnings date?
CLX's next earnings report is estimated for 2026-11-02 — about 4 days away.
What is the analyst price target for CLX?
The consensus analyst price target for CLX is $90.43, about 2.0% above the current $88.67. Over the past 90 days, analysts recorded 0 upgrades, 13 maintains, and 0 downgrades.
How BestStocks tracks CLX
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared CLX-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for CLX, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 29, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.